Source: Health Canada shortage reports · Updated Nov 2, 2026
Some Gemcitabine products are in shortage in Canada (1 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2028.
Products affected
1 / 9
In shortage since
Nov 2, 2026
Est. full return
Dec 31, 2028
Reports on file
23
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · since Nov 2, 2026, est. end Dec 31, 2028 · Disruption of the manufacture of the drug.
Anticipated
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · Disruption of the manufacture of the drug.
Anticipated
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Apr 25, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Apr 19, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Apr 19, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Feb 15, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Jan 24, 2024 · Disruption of the manufacture of the drug.
Avoided
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Jan 24, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
40MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02412292 · ended Dec 23, 2022 · Delay in shipping of the drug.
Discontinued
GEMCITABINE FOR INJECTION
TEVA CANADA LIMITED
DIN 02305534
Resolved
GEMCITABINE FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02305534 · ended Jun 30, 2018 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Gemcitabine is currently affected by an active shortage report filed with Health Canada by PFIZER CANADA ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Gemcitabine is classified under “ANTIMETABOLITES” (ATC L01BC).
Recent changes
Oct 27, 2026
Status changed
Oct 1, 2026
New report filed
Oct 1, 2026
New report filed
Oct 1, 2026
Estimated end date pushed back : Mar 31, 2027 → Dec 31, 2028
Aug 7, 2026
New report filed
Common questions
When will Gemcitabine be back in stock in Canada?
The latest manufacturer estimate is Dec 31, 2028. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Gemcitabine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.